N/A
N=12
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
Cavities of Teeth
Bottom Line
View on ClinicalTrials.gov: NCT03722264 ↗Enrolled (actual)
12
Serious AEs
—
Results posted
Feb 2020
Primary outcome: Primary: Loss of Mineral Density in the Enamel — 70.8; 77.4 microns
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- OpalSeal (Device); TransbondXT (Device)
- Age
- Pediatric, Adult, Older Adult · 10+ yrs
- Sex
- All
- Sponsor
- Virginia Commonwealth University
- Primary completion
- Apr 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Loss of Mineral Density in the Enamel |
70.8; 77.4 | — |
| SECONDARY Surface Topography and Hardness |
— | — |
| SECONDARY Retention of OpalSeal |
28.1 | — |
Summary
Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbond XT) during treatment with braces.
Eligibility Criteria
Inclusion Criteria
- Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes
- Such teeth should be free of any developmental defects
Exclusion Criteria
- Patients under 10 years of age
- Patients with defective teeth
- Those who cannot provide consent/assent OR not able to follow research protocols
- Protected population (prisoners)
Data sourced from ClinicalTrials.gov (NCT03722264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.